Carboplatin (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Carboplatin drug offered from Mylan Institutional LLC. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Carboplatin
SUBSTANCE NAME: CARBOPLATIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-11-09
END MARKETING DATE: 0000-00-00


Carboplatin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCarboplatin from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2011-11-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-491_5677d335-1e80-4ec0-b1a9-8143856e7a34
PRODUCT NDC: 67457-491
APPLICATION NUMBER: ANDA091063

Other CARBOPLATIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.Carboplatin
Fresenius Kabi USA, LLCCarboplatin
Gland Pharma LimitedCARBOPLATIN
Hospira, Inc.Carboplatin
Ingenus Pharmaceuticals, LLCCarboplatin
Meitheal Pharmaceuticals Inc.Carboplatin
Mylan Institutional LLCCarboplatin
Sagent PharmaceuticalsCarboplatin
Sandoz IncCarboplatin
Sanja Pharmaceuticals CompanyCarboplatin
Sun Pharma Global FZEcarboplatin
Teva Parenteral Medicines, Inc.CARBOplatin